Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 34 studies | 47% ± 23% | |
| connective tissue cell | 16 studies | 49% ± 23% | |
| smooth muscle cell | 10 studies | 27% ± 9% | |
| pericyte | 8 studies | 39% ± 21% | |
| myofibroblast cell | 6 studies | 47% ± 18% | |
| mesothelial cell | 4 studies | 36% ± 19% | |
| adventitial cell | 4 studies | 49% ± 12% | |
| myeloid cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 99% | 5307.51 | 453 / 459 | 97% | 89.58 | 1086 / 1118 |
| ovary | 100% | 10143.88 | 180 / 180 | 93% | 58.32 | 400 / 430 |
| prostate | 99% | 3635.36 | 242 / 245 | 93% | 43.72 | 466 / 502 |
| lung | 99% | 4628.21 | 573 / 578 | 88% | 46.62 | 1015 / 1155 |
| uterus | 100% | 10380.85 | 170 / 170 | 67% | 60.53 | 307 / 459 |
| skin | 94% | 7920.57 | 1705 / 1809 | 72% | 64.19 | 340 / 472 |
| intestine | 96% | 4411.95 | 932 / 966 | 68% | 25.94 | 359 / 527 |
| bladder | 100% | 6139.57 | 21 / 21 | 61% | 26.96 | 308 / 504 |
| stomach | 82% | 3508.42 | 295 / 359 | 77% | 32.03 | 221 / 286 |
| pancreas | 63% | 870.97 | 206 / 328 | 93% | 66.88 | 165 / 178 |
| thymus | 85% | 1900.27 | 555 / 653 | 65% | 24.00 | 394 / 605 |
| esophagus | 89% | 2844.74 | 1292 / 1445 | 55% | 15.62 | 100 / 183 |
| kidney | 64% | 1566.81 | 57 / 89 | 70% | 28.02 | 634 / 901 |
| adrenal gland | 82% | 1541.59 | 212 / 258 | 38% | 11.35 | 87 / 230 |
| brain | 10% | 113.28 | 253 / 2642 | 92% | 58.94 | 651 / 705 |
| adipose | 100% | 5720.48 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 97% | 3201.24 | 1301 / 1335 | 0% | 0 | 0 / 0 |
| heart | 77% | 2123.90 | 659 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 76% | 21.29 | 34 / 45 |
| liver | 43% | 578.70 | 97 / 226 | 30% | 10.62 | 121 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 7.70 | 12 / 29 |
| eye | 0% | 0 | 0 / 0 | 35% | 9.86 | 28 / 80 |
| spleen | 22% | 245.32 | 54 / 241 | 0% | 0 | 0 / 0 |
| muscle | 17% | 214.37 | 133 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.87 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_1903561 | Cellular component | extracellular vesicle |
| GO_0005615 | Cellular component | extracellular space |
| Gene name | OLFML3 |
| Protein name | Olfactomedin like 3 (cDNA FLJ58142, highly similar to Olfactomedin-like protein 3) Olfactomedin-like 3, isoform CRA_b (Olfactomedin-like protein 3) Olfactomedin-like protein 3 (HNOEL-iso) (hOLF44) |
| Synonyms | UNQ663/PRO1294 PSEC0244 hCG_38642 PSEC0035 PSEC0173 |
| Description | FUNCTION: Secreted scaffold protein that plays an essential role in dorsoventral patterning during early development. Stabilizes axial formation by restricting chordin (CHRD) activity on the dorsal side. Acts by facilitating the association between the tolloid proteases and their substrate chordin (CHRD), leading to enhance chordin (CHRD) degradation (By similarity). May have matrix-related function involved in placental and embryonic development, or play a similar role in other physiological processes. . |
| Accessions | B4DNG0 ENST00000369551.5 [Q9NRN5-2] Q9NRN5 M1LAK4 ENST00000320334.5 [Q9NRN5-1] ENST00000393300.6 |
